Showing results (31-40 of 112) with videos related to
Sort By:
Pageof 12
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|January 25, 2020
Lipidomic characterization of exosomes isolated from human plasma using various mass spectrometry techniquesOndřej Peterka, Robert Jirásko, Michaela Chocholoušková, et al.Transfusion|July 1, 2021
Washing transplants with Sepax 2 reduces the incidence of side effects associated with autologous transplantation and increases patients' comfortLucie Huvarová, Zdeněk Kořístek, Tomáš Jelínek, et al.Journal of the American Society for Mass Spectrometry|January 27, 2023
Separation of Isomeric Tau Phosphopeptides from Alzheimer's Disease Brain by Cyclic Ion Mobility Mass SpectrometryAndrej Kováč, Petra Majerová, Marianna Nytka, et al.Nuclear Medicine and Biology|December 17, 2011
Measuring diffuse metabolic activity on FDG-PET/CT: new method for evaluating Langerhans cell histiocytosis activity in pulmonary parenchymaPetr Szturz, Zdeněk Řehák, Renata Koukalová, et al.British Journal of Haematology|August 8, 2019
Development and validation of a novel risk stratification algorithm for relapsed multiple myelomaRoman Hájek, Michel Delforge, Marc S Raab, et al.Haematologica|December 18, 2012
Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trialMeletios A Dimopoulos, Michel Delforge, Roman Hájek, et al.Clinical Lymphoma, Myeloma & Leukemia|January 13, 2015
Analysis of B-cell subpopulations in monoclonal gammopathiesPavla Všianská, Lucie Říhová, Tamara Varmužová, et al.Journal of Translational Medicine|March 16, 2023
Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibilityPiotr Celichowski, Marcello Turi, Sandra Charvátová, et al.Analytical and Bioanalytical Chemistry|July 29, 2018
HILIC/ESI-MS determination of gangliosides and other polar lipid classes in renal cell carcinoma and surrounding normal tissuesRoman Hájek, Miroslav Lísa, Maria Khalikova, et al.Molecular Diagnosis & Therapy|March 30, 2026
The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and ResistanceKlára Baďurová, Veronika Kapustová, Jana Kotulová, et al.Pageof 12